News | Breast Density | March 22, 2018 | Emily Clemons

Three More States Pass Breast Density Notification Bills

Thirty-two states now legally require a patient be notified of their breast density after a mammogram 

Three More States Pass Breast Density Notification Bills. Bi-RADS score for breast density Bi-rads 1 to 4

Mammography images showing, from left to right, BI-RADS breast tissue density scores from 1 to 4.

March 22, 2018 – Utah, Washington state and Florida have all recently mandated that patients be notified of their breast density after undergoing screening mammograms.

Utah’s bill, House Bill 258, amends a 2012 law that previously did not require patient notification, but encouraged it and offered suggested language to include in a patient’s mammogram results. The amendment not only requires breast density notification, but also clarifies the language to be used in notification. Utah Gov. Gary Herbert signed the amendment into law this month, and it takes effect May 8, 2018.

Washington state Governor Jay Inslee recently signed Senate Bill 5040 into law, and it will take effect Jan. 1, 2019. Unlike other state laws, every patient must be notified of their breast density after screening mammography, regardless of their classification. Patients with heterogeneously dense or extremely dense breast tissue will receive specific notification about its effects on their mammogram and cancer risk factors.

Florida’s Senate Bill 164, which was unanimously passed by the House and the Senate, requires facilities performing mammography to notify patients of their breast density if they are found to have heterogeneously dense or extremely dense breast tissue. Florida Gov. Rick Scott is soon expected to sign the bill into law, and it will take effect July 1, 2018.

"I am pleased that the reporting of dense breast tissue as part of a patient's mammography screening results will now be standardized across the state of Florida. This information will lead to informed conversations between patients and healthcare providers about a woman's cancer risk and screening options, " reported Florida State Sen. Denise Grimsley (R-D26), who championed the bill after her constituent, Debbie McCullough of Lake Placid, Fla., was diagnosed with breast cancer within months of her regular mammogram.

While all breasts are made of glands, fibrous tissue and fat, dense breast tissue has more glands and fibrous tissue than it does fat. Dense, fibroglandular tissue is normal and affects about 50 percent of women under age 50. Breast density is determined during a screening mammogram and is classified as either fatty, scattered, heterogeneously dense or extremely dense. Those with heterogeneously dense or extremely dense breast tissue have cause for concern, as dense tissue makes reading mammograms more difficult because both tumors and dense tissue appear white on the scans. Additionally, dense tissue increases a patient’s breast cancer risk by four to six times.

Many of these breast density reporting laws would not have passed without the work of Nancy Capello, Ph.D., who worked closely with Sen. Grimsley and Florida State Rep. Gayle Harrell (R-D83) to pass the bill. Connecticut’s 2009 bill — the first in the U.S. — was informed by Capello’s advocacy after her own diagnosis of stage 3c breast cancer, metastasized to 13 lymph nodes, that was discovered within weeks of her eleventh normal mammogram. Only at the time of her diagnosis was she informed of her breast density. This experience inspired her to found Are You Dense Inc. and Are You Dense Advocacy Inc.

For more information about breast density and notification: www.densebreast-info.org

Related Content:

VIDEO: Personalized Breast Screening and Breast Density

VIDEO: The Impact of Breast Density Technology and Legislation

 

Related Content

Christopher Comstock, M.D., ECOG-ACRIN Cancer Research Group study published in JAMA builds evidence for use of abbreviated MRI in women with dense breasts

Christopher Comstock, M.D., (Memorial Sloan Kettering Cancer Center) is the lead author of a paper in JAMA that reports that abbreviated breast MRI detected significantly more (almost 2 and a half times as many) breast cancers than digital breast tomosynthesis (3-D mammography) in average-risk women with dense breasts. Photo courtesy of Memorial Sloan Kettering Cancer Center

News | Breast Imaging | February 26, 2020
February 26, 2020 — According to a study
Women 75-plus May Not Benefit from Breast Cancer Screening
News | Mammography | February 25, 2020
February 25, 2020 — According to newly published research in an article titled...
Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Radiology Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast. A small mass with micro-calcifications on the right-side breast was detected correctly by AI with an abnormality score of 96%. This case was recalled by 7 out of 14 radiologists (4 breast radiologists and 3 general radiologists) initially (without AI) and all 14 radiologists recalled this case correctly with the assistance of AI.

News | Artificial Intelligence | February 11, 2020
February 11, 2020 — A new study, published in...
Sponsored Content | Videos | Artificial Intelligence | February 06, 2020
ProFound AI is an FDA-cleared artificial intelligence (AI) system for reading 3-D breast tomosynthesis images.
Feature | Breast Imaging | February 03, 2020 | By Barbara Smith
Women in the United States have a 1 in 8 (or about 13 percent) lifetime risk of being diagnosed with breast cancer du
ringing the cancer bell can do more harm than good, says an ASTRO study

Image courtesy of ASTRO

News | Radiation Oncology | January 27, 2020
January 27, 2020 — It's a scene that some cancer patients dream about: they celebrate the end of a course of radiatio
A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast

A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast. (A) Unenhanced fat-saturated T1-weighted MRI shows extreme amount of FGT (ACR d). (B) Moderate BPE is seen on dynamic contrast-enhanced MRI at 90 s. (C) Mean ADC of breast parenchyma of contralateral breast on diffusion-weighted imaging with ADC mapping is 1.5 × 10?3 mm2/s. (D) On 18F-FDG PET/CT, lesion is not 18F-FDG-avid, and BPU of normal breast parenchyma is relatively high, with SUVmax of 3.2. Photo courtesy of K Pinker, et al., Medical University of Vienna, Vienna, Austria

News | PET-MRI | January 27, 2020
January 27, 2020 — Researchers have identified several potentially useful...